Page 4,034«..1020..4,0334,0344,0354,036..4,0404,050..»

Harborcreek man to seek MS treatment in Panama

Posted: Published on June 26th, 2014

Bill Anderson felt like he was in the best shape of his life when doctors diagnosed him with multiple sclerosis in 2001. The Harborcreek Township real estate agent's regular workouts were interrupted by a sudden numbness in his abdomen that radiated down to his feet. "I went to the emergency room and was later admitted to the hospital," said Anderson, now 49. "They did some tests and diagnosed me with relapsing-remitting multiple sclerosis. I was stunned." Anderson has fought MS for 13 years, giving as little ground as he can to the relentless disease. He still works full time but now walks with a cane or a walker when the terrain is uneven. His symptoms have worsened in recent years and traditional medications aren't helping him much. So Anderson is ready to take a drastic step: Spend $25,000 to travel to Panama for stem cell treatments. "I'm not going to lie down and let this disease take me down, when there may be something out there to help me," Anderson said. He is preparing to visit the Stem Cell Institute in Panama City in July and undergo intravenous injections of stem cells as a treatment for MS. The stem cells … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Harborcreek man to seek MS treatment in Panama

Animal study unveils predictive marker for epilepsy development following febrile seizure

Posted: Published on June 25th, 2014

PUBLIC RELEASE DATE: 24-Jun-2014 Contact: Emily Ortman media@sfn.org 202-962-4090 Society for Neuroscience Washington, DC Within hours of a fever-induced seizure, magnetic resonance imaging (MRI) may be able to detect brain changes that occur in those most likely to develop epilepsy later in life, according to an animal study published in the June 25 issue of The Journal of Neuroscience. The findings may one day help improve methods to detect children at a heightened risk for developing epilepsy and guide efforts to prevent epilepsy development in those at greatest risk. Febrile seizures convulsions brought on by fever typically last only a few minutes and are relatively common in infants and small children. However, in some cases, children experience febrile seizures that last for more than 30 minutes (known as febrile status epilepticus, or FSE). Of these children, 40 percent will go on to develop temporal lobe epilepsy (TLE) a common and often treatment-resistant brain disorder. Physicians currently have no way to anticipate which of the children with a history of extended febrile seizures (FSE) will go on to develop TLE, and children typically do not experience the onset of the disease until 10-12 years after the onset of FSE. In the … Continue reading

Comments Off on Animal study unveils predictive marker for epilepsy development following febrile seizure

PostEverything: The FDA may ban the treatment keeping our daughter alive

Posted: Published on June 25th, 2014

By Mitchell and Marcia Shear June 24 Dr. and Mrs. Shears daughter, Samantha, has been a student at the Judge Rotenberg Center in Canton, Mass., since 2005. He is an internist. They live in Roslyn Heights, New York. Samantha, our 21-year-old daughter, attacked other children, her teachers, and us. She bit, scratched, kicked, hit, pinched, and head-butted whoever was in range. Her relentless compulsion for self-abuse led her to throw herself on the floor.When she was 12 years old, she finally hit herself in the head hard enough to detach both retinas, rendering herself virtually blind. Her autism was so bad that it proved impervious to professional therapists, powerful medications, and the love of her parents and siblings. She was expelled from numerous schools and treatment centers. Her life was in danger. Then, after years of this self-abuse, something happened. We found a program for Samantha that actually works the Judge Rotenberg Educational Center (JRC) in Canton, Mass. JRCs behavioral treatment, including a controversial electrical device, is a program of last resort to treat children and adults with life-threatening behavior disorders that are resistant to all other forms of psychological and psychiatric care.The results are life-changing. Within several weeks of … Continue reading

Comments Off on PostEverything: The FDA may ban the treatment keeping our daughter alive

How Connecticut's Change In Autism Coverage Could Make Waves

Posted: Published on June 25th, 2014

Many families with children who have autism count on their insurance to help pay for expensive, long-term treatment. But a recent bulletin issued by the Connecticut Insurance Department may undermine existing coverage protections, some advocates say, and they are concerned that other states might follow suit. Autism spectrum disorder affects 1 in 68 children, according to the federal Centers for Disease Control and Prevention. The developmental disorder includes a range of conditions that are characterized by difficulties in communication and social interaction as well as repetitive behaviors. In recent years, advocates for people with autism and their families have pushed hard to get better insurance coverage, prompting 37 states and the District of Columbia to pass laws that require insurers to cover autism treatment, according to Autism Speaks, an advocacy organization. In addition, some advocates look to new policies on mental health coverage to aid families. Until recent years, coverage for mental health conditions was often significantly more limited than coverage for physical ailments. The Mental Health Parity and Addiction Equity Act of 2008 required that mental health benefits be covered at least as generously as medical/surgical benefits in large group plans. The Affordable Care Act extended those protections this … Continue reading

Comments Off on How Connecticut's Change In Autism Coverage Could Make Waves

Advocates worry Connecticut decision may chip away at hard-won gains for autism coverage

Posted: Published on June 25th, 2014

Today, many families with autistic childrencount on their insurance coverage to help pay for the often expensive, long-term treatment their kids need. But advocates and public policy experts say a recent bulletin issued by the Connecticut Insurance Department may undermine existing coverage protections and they're concerned that other states might follow suit. Autism spectrum disorder affects 1 in 68 children, according to the federal Centers for Disease Control and Prevention. The developmental disorder includes a range of conditions that are characterized by difficulties in communication and social interaction as well as repetitive behaviors. In recent years, advocates for people with autism and their families have pushed hard to get better insurance coverage, prompting 37 states and the District of Columbia topasslaws that require insurers to cover autism treatment, according to Autism Speaks, an advocacy organization. In addition, some advocates look to new policies on mental health coverage to aid families. Until recent years,coverage for mental health conditions was often significantly more limited than coverage for physical ailments. The Mental Health Parity and Addiction Equity Act of 2008 required that mental health benefits be covered at least as generously as medical/surgical benefits in large group plans. The Affordable Care Act extended … Continue reading

Comments Off on Advocates worry Connecticut decision may chip away at hard-won gains for autism coverage

Saint Lukes Hospital of Kansas City Honored by American Heart Association and American Stroke Association with Top …

Posted: Published on June 25th, 2014

Kansas City, Mo. (PRWEB) June 25, 2014 Saint Lukes Hospital of Kansas City has received top honors from the American Heart Association/American Stroke Association for excellence in the treatment of stroke patients. The hospital was awarded the Get With The Guidelines Gold Plus Quality Achievement Award and the Target: Stroke Honor Roll, the most prestigious honors for stroke programs awarded by the organization. The Gold Plus Award is reserved for stroke centers that meet quality achievement measures for the diagnosis and treatment of stroke patients for a designated period. These measures include the aggressive use of medications and risk-reduction therapies aimed at reducing death and disability and improving the lives of stroke patients. Quality achievement measures include the implementation of antithrombotic therapy, tissue plasminogen activator (tPA), stroke education such as recognizing symptoms of stroke and learning to call 911 immediately, and more for every stroke patient. Saint Lukes Hospital also achieved the Target: Stroke Honor Roll for meeting stroke quality measures that reduce the time between hospital arrival and treatment with the clot-buster, tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke. Persons who suffer a stroke who receive the drug within three … Continue reading

Comments Off on Saint Lukes Hospital of Kansas City Honored by American Heart Association and American Stroke Association with Top …

Taking the "Random" Out: New Approach to Medical Studies Could Boost Participation

Posted: Published on June 25th, 2014

Contact Information Available for logged-in reporters only Newswise ANN ARBOR, Mich. Its a classic Catch-22: Medical researchers need to figure out if a promising new treatment is truly better than a current one, by randomly assigning half of a group of patients to get each treatment. But when they approach patients about taking part in the study, those 50-50 random odds dont sound good enough and the study struggles to get enough volunteers. That slows down the effort to improve treatment for that condition. Now, new research shows the promise of an approach that takes some of the random out of the process, while preserving the ability to compare treatments. Instead of every patient getting a randomly chosen treatment, the approach adjusts the odds as the study goes along. So if early results show that one of the two treatments appears to work better, each new patients odds of getting that treatment increase. Its called response-adaptive randomization, or RAR. In a new brief report in the journal Stroke, University of Michigan Medical School researchers report the results of how 418 emergency department patients responded to the two approaches to medical studies. The researchers asked the patients to imagine they had … Continue reading

Comments Off on Taking the "Random" Out: New Approach to Medical Studies Could Boost Participation

Brainsway Parkinson Treatment English Subs – Video

Posted: Published on June 25th, 2014

Brainsway Parkinson Treatment English Subs By: Brainsway Deep TMS … Continue reading

Posted in Parkinson's Treatment | Comments Off on Brainsway Parkinson Treatment English Subs – Video

Deep brain stimulation improves non motor symptoms in Parkinson's disease

Posted: Published on June 25th, 2014

PUBLIC RELEASE DATE: 25-Jun-2014 Contact: Daphne Watrin d.watrin@iospress.nl 31-206-883-355 IOS Press Amsterdam, NL, 25 June 2014 Deep brain stimulation (DBS) has become a well-recognized non-pharmacologic treatment that improves motor symptoms of patients with early and advanced Parkinson's disease. Evidence now indicates that DBS can decrease the number and severity of non motor symptoms of patients with Parkinson's disease (PD) as well, according to a review published in the Journal of Parkinson's Disease. "Non motor features are common in PD patients, occur across all disease stages, and while well described, are still under-recognized when considering their huge impact on patients' quality of life," says Lisa Klingelhoefer, MD, a fellow at the National Parkinson Foundation International Centre of Excellence, Department of Neurology, King's College Hospital and King's College, London. For example, DBS of the subthalamic nucleus (STN) is effective for alleviating sleep problems and fatigue associated with PD, producing noticeable long-term improvements in sleep efficiency and the quality and duration of continuous sleep. DBS also decreases nighttime and early morning dystonia and improves nighttime mobility. "DBS can contribute to better sleep, less daytime somnolence, improved mobility, and less need for dopamine replacement therapy," says Dr. Klingelhoefer. The effects of DBS on some … Continue reading

Posted in Parkinson's Treatment | Comments Off on Deep brain stimulation improves non motor symptoms in Parkinson's disease

Conditions in adults thought of as childhood diseases

Posted: Published on June 25th, 2014

There are a number of conditions that are commonly thought of as childhood disorders that can either begin in childhood and extend into adulthood or even start in adolescence or adulthood. These include muscular dystrophy, cerebral palsy, fragile X syndrome and attention deficit disorders. Fragile X syndrome is typically a condition mostly, but not exclusively, affects young boys with variable symptoms of learning disabilities, intellectual impairment, autism, unsteadiness, tremor and seizures. The problem is with a chromosome that produces abnormal amounts of RNA. Mild cases can be virtually asymptomatic. More severe cases can show some of the above symptoms in addition to seizures, mood instability, aggression, ovarian insufficiency, fibromyalgia, hypothyroidism and neuropathy. In adults there are physical features associated with this including a long face, prominent earlobes, high arched palate, mitral valve prolapse, dilated aortic arch, flat feet, excessively flexible finger joints, soft velvet -like skin and large testicles. There is no specific treatment for fragile X syndrome but a number of medications can help the symptoms including mood stabilizers, medications for memory; hypertension which can be present and can be treated, and educational programs for autism and attention deficit. Muscular dystrophy is typically thought of as a pediatric disorder … Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on Conditions in adults thought of as childhood diseases

Page 4,034«..1020..4,0334,0344,0354,036..4,0404,050..»